INFLIXIMAB

Impact on direct and indirect costs of switching patients with inflammatory bowel disease from intravenous to subcutaneous infliximab (CT-P13)
Isabel Carbery, Gemma Burdge, Tanya Clark, Giacomo Broglio, Dan Greer, Alaa Alakkari, Christian Philipp Selinger

BMJ Open Gastroenterology Feb 2023, 10 (1) e001105; DOI: 10.1136/bmjgast-2023-001105
Association between 6-thioguanine nucleotide levels and preventing production of antibodies to infliximab in patients with inflammatory bowel disease
Jennifer Phillips, Sam Leary, Jonathan Tyrrell-Price

BMJ Open Gastroenterology Jun 2023, 10 (1) e001149; DOI: 10.1136/bmjgast-2023-001149
Controversies in the management of anti-TNF therapy in patients with Crohn’s disease: a Delphi consensus
Yago González-Lama, Elena Ricart, Daniel Carpio, Guillermo Bastida, Daniel Ceballos, Daniel Ginard, Ignacio Marin-Jimenez, Luis Menchen, Fernando Muñoz

BMJ Open Gastroenterology Jan 2024, 11 (1) e001246; DOI: 10.1136/bmjgast-2023-001246
Genetic polymorphisms in tumour necrosis factor receptors (TNFRSF1A/1B) illustrate differential treatment response to TNFα inhibitors in patients with Crohn’s disease
Ahmad Qasem, Seela Ramesh, Saleh A Naser

BMJ Open Gastroenterology Feb 2019, 6 (1) e000246; DOI: 10.1136/bmjgast-2018-000246
Successful use of TNFα blockade in a severe case of idiopathic non-granulomatous ulcerative jejunoileitis associated with thrombotic thrombocytopenic purpura
Fabian Braun, Victor Suarez, Johanna Dinter, Stefan Haneder, Alexander Quaas, Thomas Benzing, Dirk Nierhoff, Roman-Ulrich Müller

BMJ Open Gastroenterology Feb 2019, 6 (1) e000252; DOI: 10.1136/bmjgast-2018-000252
Serum trough levels of infliximab are not associated with peripheral arthralgia activity in patients with inflammatory bowel disease
Shaina Sekhri, Bharat Rao, Akanksha Mohananey, Poonam Beniwal-Patel, Alexandra Bruss, Daniel J Stein, Andres J Yarur

BMJ Open Gastroenterology Nov 2021, 8 (1) e000788; DOI: 10.1136/bmjgast-2021-000788
Top-down Infliximab Study in Kids with Crohn's disease (TISKids): an international multicentre randomised controlled trial
M A Cozijnsen, M van Pieterson, J N Samsom, J C Escher, L de Ridder

BMJ Open Gastroenterology Dec 2016, 3 (1) e000123; DOI: 10.1136/bmjgast-2016-000123

Log in using your username and password

Main menu

Log in using your username and password

You are here

INFLIXIMAB